Board approves three investment plans Spike Pharmaceuticals expands again
Release time:
2020-08-14
News from our newspaper 8# April 3 , the group company held the fifth meeting of the 10th board of directors, deliberated and passed three proposals on the capital increase of Shanghai Beika by Jianfeng Pharmaceutical, the acquisition of Anhui Zhongwang Pharmaceutical Company by subsidiary Shanghai Beika, and the annual production of 20 .8 billion solid preparations in Jinxi Production Base of Jianfeng Pharmaceutical.
The three investment plans approved by the board of directors this time are important measures to further strengthen the company's pharmaceutical business segment in accordance with the company's strategic policy of "cooperating and innovating to strengthen the main business, standardizing science and seeking development. Among them, Jianfeng Pharmaceutical Co., Ltd. invested ,000 yuan to increase the capital of Shanghai North Card. After the capital increase is completed, Jianfeng Pharmaceutical Co., Ltd. will account for 61.48% of Shanghai North Card. Shanghai North Card will invest 2062 yuan to acquire Anhui Zhongwang 100% equity.
In 1 this year, Jianfeng Pharmaceutical signed an agreement with relevant parties to invest in Shanghai Beika by way of equity acquisition and capital increase, and completed the investment in 5 . Shanghai Beika and its subsidiary Anhui Xinbeika Company have become the controlling subsidiary of Jianfeng Pharmaceutical. Anhui Zhongwang, which Shanghai Beika acquired this time, is also located in Dongzhi Xiangyu Chemical Industrial Park, Chizhou City, Anhui Province. It is a pharmaceutical intermediate manufacturing enterprise integrating R & D, production and sales, focusing on the R & D, production and sales of characteristic medicines, intermediates, new materials and other fine chemicals. Anhui Zhongwang's main products are oxyfluorocarbons, oxyfluorocarbons, levooxyfluorocarbons, and levooxyfluorocarbons, which have passed on-site audits by well-known domestic pharmaceutical companies. L-fluorocycloester passed an on-site audit of a pharmaceutical company in India. 2017 12 accepted the on-site audit of oxyfluorocarboxylic acid process verification by U.S. pharmaceutical companies, and Zhongwang has been registered as a supplier of oxyfluorocarboxylic acid starting materials in U.S. document DMF . After the completion of the acquisition, the company will make use of Anhui Zhongwang's factory buildings and construction land to plan the construction of pharmaceutical intermediates and API projects, so as to provide a strong guarantee for Jianfeng Pharmaceutical to establish a chemical API base.
At the same time, Jianfeng Pharmaceutical will also invest 50146 yuan to set up a new factory on the north side of the existing factory area of Jianfeng Pharmaceutical in Jinxi District of Jinhua Economic Development Zone to build a preparation manufacturing platform that meets the requirements of GMP in Europe and America. (remaining fruit)
More information
The company organized "charity one day donation"
On the morning of October 22, in the lobby on the first floor of Jianfeng Building, all cadres and employees of the group headquarters and subordinate enterprises working in Jianfeng Building participated in the 2021 "Charity Day Donation" activity to offer their love to Jinhua charity. In the next few days, the company's subordinate enterprises also organized "charity one-day donation" activities one after another.
2021
11-01
The company organizes new employee induction training
"Growth is more important than success. I hope everyone can become the backbone and pillars of the peak as soon as possible." On September 2, Yu Jianhong, general manager of the group company, put forward ardent hopes in the face of new employees. On the 2nd and 3rd, the group company organized induction training for new employees recruited in the past year. The group company chairman Jiang Xiaomeng, general manager Yu Jianhong and other leaders and relevant department heads gave lectures to them.
2021
09-13
Daye Peak: Typical Regional Industrial Green Development
On August 23, Huangshi Radio and Television Station broadcast the special program of "Strengthening Overall Planning and Promoting Energy Saving and Emission Reduction in Industrial Field". Daye Jianfeng Cement Company, as a typical enterprise with outstanding achievements in establishing green factories and energy saving and emission reduction in Huangshi area, appeared in the program.
2021
09-01
Yunnan Peak Helps Border Epidemic Prevention and Control
On August 22, Yunnan Peak Cement Company, through the Red Cross Society of Pu'er City and the Epidemic Prevention Headquarters of Pu'er City, donated vacuum insulation pots with a total value of 800000 yuan to the four border counties for the prevention and control of the new coronary pneumonia epidemic in the border area, and supported the prevention and control of the epidemic at the border with practical actions.
2021
09-01
Group Party Committee to Learn "July 1" Important Speech
On August 13, the party committee of the group company held a special meeting to collectively study General Secretary Xi Jinping's important speech at the celebration meeting of the 100 anniversary of the founding of the Communist Party of China, convey the requirements of the party committee at a higher level, and make arrangements for organizing party members of the company to study the "July 1" speech.
2021
08-23
Spike Ranked 2020 China's Top 100 Cement Clinker Production Capacity
Recently, the company received the "2020 China Cement Clinker Production Capacity Top 100" plaque issued by China Cement Network. The ranking of China's top 100 cement clinker production capacity is organized and evaluated by China Cement Network, an authoritative information platform for the domestic cement industry. It is released according to the actual clinker production capacity of each cement enterprise at the end of last year. The company has been ranked in the top 100 list for many consecutive years.
2021
08-23